Thrasos Therapeutics
Discovers and develops targeted therapies for the prevention and treatment of severe organ failures.
Launch date
Employees
Market cap
-
Enterprise valuation
$84—126m (Dealroom.co estimates Mar 2015.)
Montreal Quebec (HQ)
Authorizing premium user...